A) Proteasomal degradation was necessary for decreased CK1α as the proteasomal inhibitor, Lactacystin (10 μmol/L), blocked SDF-dependent β-catenin whereas the lysosomal inhibitor, E64C (10 μmol/L), did not. C) β-Catenin was ubiquitinated, however, CK1α was not. D) CSPC SDF1 treatment, 25 nM for 1 and 6 hours, decreased CK1α mRNA levels. Values are the mean ± SE, n=3. * p<0.05 vs Veh.